Rational Drug Use (Rdu) Based on Patient Care Indicator in Primary Health Center in Semarang

Abstract

Rational Drug Use has several indicators, one of which is service indicators, where service indicators will play a role in increasing rational drug use so that it can support the success of treatment to achieve a better quality of life and patient welfare. The purpose of this study was to determine rational drug use in the city of Semarang based on service indicator parameters. This research is a descriptive-analytic with a cross-sectional design, data collection is done prospectively with a direct observation approach and direct interviews with respondents. The number of respondents was 744 patients (372 at Puskesmas N and 372 at Puskesmas TK who were taken by consecutive sampling. The data were processed using the Mann-Whitney statistical test with a p-value <0.05. The results of this study indicate that the use of drugs in Puskesmas N and Puskesmas TK There is a significant difference with a p-value <0.05. In the meantime of medical consultation 5-11 minutes; the average time for drug preparation 10-16 minutes; the percentage of drug delivery suitability is 100%; the percentage of adequate labeling is 100% and the percentage of knowledge Patients at the puskesmas approach rationality and there are differences in services between the two Puskesmas. The government needs to increase the number of pharmacists and improve infrastructure, especially in terms of drug counseling at each puskesmas so that it is hoped that patient knowledge of the drug regimen to be consumed will increase.

Factors Associated With Rationality of Antimalaria Prescription in Papua Province

“…Therefore, malaria eradication has been prioritized to be targeted as one of the Millennium Development Goals (World Health Organization & WHO, 2020). Even though the incidence cases tend to decline in some areas (Febrinasari et al, 2021), there are five provinces with high malaria incidences are Papua, East Nusa Tenggara, West Papua, Central Sulawesi, and Maluku need to be prioritized and the resistance of chloroquine adds the complexity of problems. A prior study showed that resistance to antimalarials has been reported in both P falciparum and P. vivax and this resistance is not for chloroquine alone but also to currently used for antimalarials (Farooq & Mahajan, 2004).…”